ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 656599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 656599; 2) Community: the network communities that were significantly associated with the response to NSC 656599; 3) Molecule: the relationships between components within communities and NSC 656599; 4) MDR: the compounds that were significantly associated with the NSC 656599.

NSC Compound Enrichment Correlation
NSC 153325 Null 0.000864859564133848 0.47667845
NSC 172599 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- 0.000864859564133848 0.60321256
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.000864859564133848 0.53497867
NSC 637132 Null 0.000864859564133848 0.26822747
NSC 600301 Null 0.00098268217727352 0.63961991
NSC 656280 2-Naphthalenemethanaminium, 1,2,3,4-tetrahydro-N,N,N-trimethyl-1-oxo-, iodide 0.00098268217727352 0.58740944
NSC 154751 Urea, N'-(5,6-dichloro-1H-benzimidazol-2-yl)-N,N-dimethyl- 0.00107480559257736 0.33950399
NSC 709237 Camptothecin Derivative 0.00107480559257738 -0.1208732
NSC 734626 Null 0.00107480559257738 0.060800669
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.00119931827492062 0.42010027
Total:147  Current:11    [First] [Prev] [Next] [Last]